Abstract |
Arginine methylation is carried out by protein arginine methyltransferase (PRMTs) family. Arginine methyltransferase inhibitor 1 (AMI-1) is mainly used to inhibit type I PRMT activity in vitro. However, the effects of AMI-1 on type II PRMT5 activity and gastric cancer (GC) remain unclear. In this study, we provided the first evidence that AMI-1 significantly inhibited GC cell proliferation and migration while induced GC cell apoptosis, and reduced the expression of PRMT5, eukaryotic translation initiation factor 4E ( eIF4E), symmetric dimethylation of histone 3 (H3R8me2s) and histone 4 (H4R3me2s). In addition, AMI-1 inhibited tumor growth, downregulated eIF4E, H4R3me2s and H3R8me2s expression in mice xenografts model of GC. Collectively, our results suggest that AMI-1 inhibits GC by downregulating eIF4E and targeting type II PRMT5.
|
Authors | Baolai Zhang, Su Zhang, Lijuan Zhu, Xue Chen, Yunfeng Zhao, Li Chao, Juanping Zhou, Xing Wang, Xinyang Zhang, Nengqian Ma |
Journal | Toxicology and applied pharmacology
(Toxicol Appl Pharmacol)
Vol. 336
Pg. 1-7
(12 01 2017)
ISSN: 1096-0333 [Electronic] United States |
PMID | 28987382
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Enzyme Inhibitors
- Eukaryotic Initiation Factor-4E
- Histones
- Repressor Proteins
- eIF4E protein, mouse
- PRMT1 protein, human
- PRMT5 protein, human
- Prmt1 protein, mouse
- Prmt5 protein, mouse
- Protein-Arginine N-Methyltransferases
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Dose-Response Relationship, Drug
- Down-Regulation
- Enzyme Inhibitors
(pharmacology)
- Eukaryotic Initiation Factor-4E
(metabolism)
- Female
- Histones
(metabolism)
- Humans
- Mice, Inbred BALB C
- Mice, Nude
- Protein-Arginine N-Methyltransferases
(antagonists & inhibitors, metabolism)
- Repressor Proteins
(antagonists & inhibitors, metabolism)
- Signal Transduction
(drug effects)
- Stomach Neoplasms
(drug therapy, enzymology, pathology)
- Time Factors
- Tumor Burden
(drug effects)
|